Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q3 FY23 results · Oct–Dec 2022

Advanced Enzyme Technologies reported revenue from operations of ₹142.11 crore (up 6.4% from Q3 FY22) and net profit of ₹27.91 crore (down 2.3% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations142.11133.56+6.4%138.69+2.5%
Other income8.521.21+606.1%3.87+120.0%
Total income150.63134.76+11.8%142.56+5.7%
Profit before tax40.4541.12−1.6%34.14+18.5%
Net profit for the period27.9128.55−2.3%26.26+6.3%
Attributable to shareholders of the company29.4427.48+7.1%26.21+12.3%
EPS, basic (₹)2.632.46+6.9%2.34+12.4%
Net margin (%)19.621.418.9
Standalone · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations79.6864.39+23.8%77.18+3.2%
Other income3.751.07+252.1%2.00+87.7%
Total income83.4465.45+27.5%79.18+5.4%
Profit before tax22.3111.78+89.5%18.41+21.2%
Net profit for the period16.648.77+89.7%13.62+22.2%
EPS, basic (₹)1.490.78+91.0%1.22+22.1%
Net margin (%)20.913.617.6
Consolidated
Filed with BSE
13 Feb 2023, 10:10 IST
Board meeting
11 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
13 Feb 2023, 10:10 IST
Board meeting
11 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE